SJS Investment Consulting »

Vanda Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2025-12-31 $185 21 8.86

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Eqt Etf (AVUS)
Hormel Foods Corporation (HRL)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Dimensional Etf Trust World Ex Us Core (DFAX)
NVIDIA Corporation (NVDA)

View all positions for SJS Investment Consulting

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
AIGH Capital Management
Millennium Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Empire Financial Management Company
Two Sigma Advisers
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Jacobs Levy Equity Management

View all funds holding Vanda Pharmaceuticals